{"organizations": [], "uuid": "7e8c5534a799d383d36e57ad40912397f2241c38", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180215.html", "section_title": "Archive News &amp; Video for Thursday, 15 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-allscripts-q4-gaap-earnings-per-sh/brief-allscripts-q4-gaap-earnings-per-share-0-03-idUSASB0C61P", "country": "US", "domain_rank": 408, "title": "BRIEF-Allscripts Q4 GAAP Earnings Per Share $0.03", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.103, "site_type": "news", "published": "2018-02-16T05:10:00.000+02:00", "replies_count": 0, "uuid": "7e8c5534a799d383d36e57ad40912397f2241c38"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-allscripts-q4-gaap-earnings-per-sh/brief-allscripts-q4-gaap-earnings-per-share-0-03-idUSASB0C61P", "ord_in_thread": 0, "title": "BRIEF-Allscripts Q4 GAAP Earnings Per Share $0.03", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "allscripts healthcare solutions inc", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 15 (Reuters) - Allscripts Healthcare Solutions Inc :\n* ALLSCRIPTS ANNOUNCES FOURTH QUARTER AND 2017 FULL-YEAR RESULTS\n* Q4 NON-GAAP EARNINGS PER SHARE $0.18\n* Q4 GAAP EARNINGS PER SHARE $0.03 * SEES FY 2018 NON-GAAP EARNINGS PER SHARE $0.72 TO $0.82\n* SEES FY 2018 REVENUE $2.15 BILLION TO $2.25 BILLION * ‍Q4 2017 GAAP REVENUE WAS $517 MILLION, AN INCREASE OF 22 PERCENT​\n* ‍SEES FY 2018 NON-GAAP REVENUE OF BETWEEN $2.15 BILLION AND $2.25 BILLION, UP 17% TO 22% VERSUS 2017​\n* ‍AMENDED ALLSCRIPTS CREDIT AGREEMENT, PROVIDING FOR AN INCREASE IN AVAILABLE LIQUIDITY AND TENOR​\n* ‍AMENDED ALLSCRIPTS CREDIT AGREEMENT, AMENDMENT PROVIDES A $400 MILLION TERM LOAN AND A $900 MILLION REVOLVING FACILITY​\n* ‍AMENDMENT PROVIDES A $400 MILLION TERM LOAN AND A $900 MILLION REVOLVING FACILITY​\n* ‍AMENDMENT REPRESENTS AN INCREASE IN BORROWING CAPACITY OF $500 MILLION AND MATURITY DATE WAS EXTENDED TO 2023​\n* Q4 EARNINGS PER SHARE VIEW $0.18, REVENUE VIEW $523.5 MILLION -- THOMSON REUTERS I/B/E/S\n* FY2018 EARNINGS PER SHARE VIEW $0.79, REVENUE VIEW $2.15 BILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-16T05:10:00.000+02:00", "crawled": "2018-02-16T16:43:49.013+02:00", "highlightTitle": ""}